top of page
Research Articles





Fasogbon Samuel Ayobami,  AjileyeAyodeji,  BlessingAbubakar, SharafudeenDahiru.

ABSTRACT: Aim: The study was carried out to determine the Immunohistochemical Correlation between the Expression of Vitamin D Receptor (VDR) and Estrogen Receptor (ER) in Invasive Ductal Carcinoma (IDC) tissues Materials and Method: A total number of fifty six (56) archived female breast Invasive Ductal Carcinoma tissue blocks were used. The tissue blocks were sectioned at not more than 2µm each. Haematoxylin and Eosin staining method and immunohistochemical staining technique using VDR and ER antibodies were done and the results were correlated.Result and Discussion: The results show that there is a significant difference (P<0.05) found comparing the imunohistochemical expression of VDR with ER in IDC tissues.Conclusion: VDR antibody cannot be use in replacement of ER antibody in the immunohistochemical diagnosis of Invasive ductal carcinoma (IDC) of the breast.


KEYWORDS: Vitamin D receptor (VDR), Estrogen receptor (ER), Invasive ductal carcinoma (IDC).


  1. Johns Hopkins (2016): Inasive Ductal Carcinoma (IDC); . Sited November, 2016

  2. Yifau, W., and Binhua, P.Z (2011): Epithelial-mesenchymal transition in breast cancer progression and metastasis; : 603-611.

  3. Viale, G (2012): The current state of breast cancer classification; 207-210.

  4. Sotiriou, C., Neo, S.Y., McShane, L.M

  5. Hosoi, T. (2002): Polymorphisms of vitamin D receptor gene. .. Suppl 3: 106–110.

  6. Uitterlinden AG, Fang Y, Van Meurs JB, Pols HA, Van Leeuwen JP (2004): "Genetics and biology of vitamin D receptor polymorphisms". : 143–156.

  7. Norman A.W. (2007)."Minireview: vitamin D receptor: new assignments for an already busy receptor".: 5542–5548.

  8. Bollag W.B. (2007): Differentiation of human keratinocytes requires the vitamin d receptor and its coactivators. : 748–750.

  9. Salashor, S., and Woodgett, J.R. (2002): Links between AXIN and carcinogenesis; :225-236

  10. Rose A.A.N, Elser C, Ennis M. (2013): Blood levels of vitamin D and early stage breast cancer prognosis: a systematic review and meta-analysis. ; :331-339.

  11. Wang, D., Velez de-la-Paz OI, and Zhai JX, (2013): Serum 25-hydroxyvitamin D and breast cancer risk: a meta-analysis of prospective studies. ; 1-9.

  12. Welsh J. (2012): Cellular and molecular effects of vitamin D on carcinogenesis. ; b:107-114

  13. Walker R. A. (2007): Immunohistochemical markers as predictive tools for breast cancer Department of Cancer Studies & Molecular Medicine, University of Leicester, Robert Kilpatrick Building, Leicester Royal Infirmary, Journal of Clinical Pathology; 61:10.1136.Accepted 8 November 2007.Published Online First 23 November 2007

  14. Naing, I., Winn, T. and Rusli, B.N. (2006). Practical issues in calculating the sample size for Prevalence studies. .;:9-14.16.

  15. Avwioro, O. G. (2014): Histochemistry and Tissue Pathology; Principle and Technique Third edition, page 133-168

  16. Marc (2009): Standard Immunohistochemistry Staining Method;

  17. Avidin Biotin Complex (ABC) Method. IHC world life science products and sevices.[cited: 20th October, 2016]

  18. Friedrich M, Villena-Heinsen C, Tilgen W, Schmidt W, Reichrat J, Axt-Fliedner R. (2002): Vitamin D receptor (VDR) expression is not a prognostic factor in breast cancer. May-Jun; :1919-1924.

  19. Friedrich M, Axt-Fliedner R, Villena-Heinsen C, Tilgen W, Schmidt W, Reichrath J (2002): Analysis of vitamin D-receptor (VDR) and retinoid X-receptor alpha in breast cancer. Journal of Histochemistry. Department of Gynecology and Obstetrics, University Hospital of Saarland, Homburg/Saar, Germany. Jan-Feb; :35-40

bottom of page